Scientific article

Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia

Published inClinical infectious diseases, vol. 36, no. 9, p. 1139-1143
Publication date2003

Little is known about the impact of human rhinovirus (HRV) and coronavirus infections in hematopoietic stem cell transplant (HSCT) recipients. We tested bronchoalveolar lavage (BAL) samples obtained from HSCT recipients with acute pulmonary infiltrates for HRV (n=122) and coronavirus (n=46) by reverse-transcriptase polymerase chain reaction. HRV RNA was detected in 6 (8%) of 77 patients, and coronavirus RNA was detected in 0 of 46 of BAL samples from HSCT recipients. The fatality rate in HRV-infected patients was high (83%), but all patients had significant coinfections, and the overall mortality rate was not different from that of patients who were negative for HRV in BAL samples. These results suggest that HRV may be a cause of lower respiratory tract infections in HSCT recipients and that its detection in BAL samples is associated with frequent copathogens. Whether the poor prognosis is due to HRV or the copathogen is not clear.

  • Adolescent
  • Adult
  • Female
  • Hematopoietic Stem Cell Transplantation/ adverse effects
  • Humans
  • Male
  • Middle Aged
  • Picornaviridae Infections/ complications/mortality
  • Pneumonia/ complications/mortality
  • Rhinovirus
Citation (ISO format)
ISON, M. G. et al. Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. In: Clinical infectious diseases, 2003, vol. 36, n° 9, p. 1139–1143. doi: 10.1086/374340
Main files (1)
ISSN of the journal1058-4838

Technical informations

Creation06/21/2010 10:24:54 AM
First validation06/21/2010 10:24:54 AM
Update time03/14/2023 3:44:14 PM
Status update03/14/2023 3:44:14 PM
Last indexation02/12/2024 6:32:20 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack